Nephrology Associates of Northern Illinois and Indiana
Contact : +1-630-573-5000
NANI Research conducts high-quality Phase II-IV clinical trials at many NANI locations, specializing research for the field of Nephrology. We are affiliated with Nephrology Associates of Northern Illinois / Indiana (NANI). NANI employs more than 120 board-certified nephrologists and has a large database of patients in facilities around Chicago and Northern Indiana. NANI Research conducts trials for many Pharmaceutical Companies, Contract Research Organizations and biotechnology companies.
NANI has set a high standard for the conduct of Clinical Trials. We provide a reliable environment in which clinical research of superior quality is conducted. All personnel involved in conducting Clinical Trials at NANI are trained with a set of Standard Operating Procedures to ensure a uniformity, dependability and quality of Clinical Trial conduction and data collection.
NANI is a dedicated Nephrology Facility. Our research expertise includes some of the following:
Email us to request more information:
Include your name, phone and a message requesting more information at About NANI Research.
Send inquiries to Nancy Cipparrone, Director of Research.
Clinical trials at our facilities are run by kidney doctors, or nephrologists. Our physician investigators are trained in the Code of Federal Regulations and International Conference on Harmonization Guidelines and are Good Clinical Practice certified.
The NANI Research Team is responsible for conducting clinical trials within the Code of Federal Regulations and International Conference Harmonization guidelines. Team members are thoroughly trained and regularly monitored for compliance to all NANI Standard Operating Procedures and Good Clinical Practice Guidelines.
Open Enrolling Studies:
A Phase 2a Multiple Ascending, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GFB-887, a TRPC5 Channel Inhibitor, in Patients with Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease.
For more information please go to the clinical trials website
Clinical Research is the foundation for advancement of medicine, offering new ways to prevent, detect and treat diseases. Clinical Trials have offered hope for people with chronic illnesses and the possibility of new kidney disease treatments in the future. Our research participants help us make this happen.
The decision to enroll in research is personal. For some, clinical trial participation may offer new investigational treatment options and hope of recovery from illness. For others, it’s a way to help people in the future. Most importantly, everyone receives skilled and compassionate care at NANI.
People who participate in research are closely monitored by physicians and research team members during their clinical trial participation. Our researchers ensure participants and families are kept informed throughout the trial and remain available for questions and additional support.
We offer research opportunities for adult individuals at sites of care throughout Chicagoland and Northwest Indiana.
Before a drug can be released and sold in the consumer market, there are many levels of approval needed. Clinical Trials are conducted to collect the data regarding overall safety and efficacy of a new drug during its development. This testing begins in the laboratory. It involves months of experimentation on animal and human cells before it reaches trial on humans. If these initial experiments are successful, the accumulated data is then sent to the FDA for approval to continue research in humans. This commences the 4 phases of a Clinical Trial. NANI conducts only Phase II, III and IV Clinical Trials.
Phase I: A new drug/treatment is tested in a small group of healthy individuals to evaluate the safety, tolerability, side effects and safe dosage.
Phase II: The same drug is given to a larger group of individuals to further determine its effectiveness, safety and overall, how well the drug works.
Phase III: The same drug is then given to even larger groups to confirm its effectiveness, side effects, and compare it to current “gold-standard” treatments already in the market.
Phase IV: After the drug/treatment has released in the market, studies are done to collect information on the drug’s effects in various populations and associated side effects with long-term usage.
NANI Research specializes in conducting high-quality Phase II-IV Clinical Trials in Nephrology at many of its NANI Clinic Locations, with access to thousands of Nephrology patients having varying common and rare diagnoses.
NANI successfully works with many Sponsors and CROs and their staff. We have productive working relationships with clinical research associates, on-site and remote, clinical trial managers, laboratories, vendors, and hospitals.
NANI implements a GCP, 21 CFR Part 11 compliant Clinical Trial Management System with e-regulatory, e-source, and e-consent capabilities making it accessible to Sponsor’s and CROs to participate in remote monitoring.
NANI Research can open a clinical trial from CDA execution to SIV in less than 8 weeks and we work with many commercial IRBs. Our research sites offer full service phlebotomy, investigational product handling, laboratory processing / shipping, and other ancillary services.